| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -29.8K | 100% | $1.34 | -$39.9K |
| Net | -1 | -29.8K | -100% | -$39.9K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Reprogrammed Interchange LLC | 10%+ Owner | $48.7M | Dec 30, 2024 | ||
| Ra Capital Management, L.P. | Director, 10%+ Owner | $32.5M | Dec 30, 2024 | ||
| 5AM Ventures VI, L.P. | 10%+ Owner | $3.22M | Nov 16, 2021 | ||
| Kush Parmar | Director, 10%+ Owner | $3.22M | Jun 14, 2022 | ||
| Robert Ang | PRESIDENT AND CEO, Director | $1.38M | Feb 6, 2025 | ||
| Nathan D. Jorgensen | Chief Financial Officer | $331K | May 6, 2024 | ||
| Tirtha Chakraborty | Chief Scientific Officer | $330K | Feb 6, 2025 | ||
| Eyal C. Attar | Chief Medical Officer | $180K | -$39.9K | -18.2% | Feb 13, 2025 |
| Han Wook Choi | Chief Financial Officer | $65.6K | Feb 3, 2025 | ||
| Amy Quinlan | Vice President of Finance | $43.3K | Nov 6, 2024 | ||
| Matthew R. Patterson | Director | May 23, 2024 | |||
| Erez Kalir | Director | Jan 6, 2025 | |||
| Fouad Namouni | Director | May 23, 2024 | |||
| Christopher Slapak | Chief Medical Officer | Feb 1, 2022 | |||
| Daniella Beckman | Director | May 23, 2024 | |||
| Joshua Resnick | Director | May 23, 2024 | |||
| David Lubner | Director | May 23, 2024 | |||
| Sven Ante Lundberg | Director | May 23, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|